SS Innovations International Relocates Executive Offices to India

TL;DR

SS Innovations International moved its HQ to India, formerly AVRA Medical Robotics.

AI Summary

SS Innovations International, Inc. filed an 8-K on October 21, 2025, reporting on events as of the same date. The filing indicates a change in the company's principal executive office location to Gurugram, Haryana, India. The company was formerly known as AVRA Medical Robotics, Inc., with a name change effective June 1, 2016.

Why It Matters

This relocation of principal executive offices could signal a strategic shift in the company's operational focus or management structure, potentially impacting its global business strategy and investor relations.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting a change in address and does not disclose significant financial or operational changes that would inherently increase risk.

Key Players & Entities

• SS Innovations International, Inc. (company) — Registrant
• AVRA Medical Robotics, Inc. (company) — Former company name
• October 21, 2025 (date) — Report date
• June 1, 2016 (date) — Date of name change
• Gurugram, Haryana, India (location) — New principal executive office location

FAQ

Filing Documents

• ea0261869-8k_ssinnova.htm (8-K) — 33KB
• ea026186901ex99-1_ssinnova.htm (EX-99.1) — 9KB
• ex99-1_001.jpg (GRAPHIC) — 4KB
• 0001213900-25-100541.txt ( ) — 216KB
• ssii-20251021.xsd (EX-101.SCH) — 3KB
• ssii-20251021_lab.xml (EX-101.LAB) — 33KB
• ssii-20251021_pre.xml (EX-101.PRE) — 22KB
• ea0261869-8k_ssinnova_htm.xml (XML) — 4KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On October 21, 2025, the Company issued a press release announcing that Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer, and Dr. Vishwa Srivastava, Chief Executive Officer – Asia Pacific, are scheduled to participate in the following upcoming investor conferences: UBS Global Healthcare Conference Palm Beach Gardens, FL Tuesday, November 11, 2025 Management will be available for one-on-one and small group meetings throughout the day. Stifel 2025 Healthcare Conference New York, NY Wednesday, November 12, 2025 Group presentation: 4:40 p.m. Eastern Time Management will be available for one-on-one and small group meetings throughout the day. A live webcast and replay of the Stifel group presentation will be accessible on the Company's website at https://ssinnovations.com/investor-overview/. A copy of the press release is included with this Report as Exhibit 99.1 . The information set forth in this Item 7.01 , in the press release included with this Report as Exhibit 99.1 , and in the Stifel group presentation which will be accessible on the Company's website through the link set forth above, are deemed to be "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01 , in the press release included with this Report as Exhibit 99.1 , and in the Stifel group presentation which will be accessible on the Company's website through the link set forth above, including without limitation, information accessed through the link set forth above, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Forward-Looking Statements

Forward-Looking Statements This Report may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "assume," "believe," "estimate," "expect," "will," "intend," "may," "plan," "project," "should," "could," "seek," "designed," "potential," "forecast," "target," "objective," "goal," or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SSi's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company's actual results to differ materially from those presented in its forward-looking statements are set forth in the Company's Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent reports. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to SSi's operations, results of operations, growth strategy and liquidity.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Press Release dated October 21, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished but not filed. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 21, 2025 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR